Skip to main content
PMC home page
Gut logoLink to Gut
. 2001 Sep;49(3):317–318. doi: 10.1136/gut.49.3.317

What comes after macrolides and other motilin stimulants?

J TACK 1, T PEETERS 1
PMCID: PMC1728448  PMID: 11511547

Full Text

The Full Text of this article is available as a PDF (63.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Coulie B., Tack J., Peeters T., Janssens J. Involvement of two different pathways in the motor effects of erythromycin on the gastric antrum in humans. Gut. 1998 Sep;43(3):395–400. doi: 10.1136/gut.43.3.395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Distrutti E., Azpiroz F., Soldevilla A., Malagelada J. R. Gastric wall tension determines perception of gastric distention. Gastroenterology. 1999 May;116(5):1035–1042. doi: 10.1016/s0016-5085(99)70006-5. [DOI] [PubMed] [Google Scholar]
  3. Feighner S. D., Tan C. P., McKee K. K., Palyha O. C., Hreniuk D. L., Pong S. S., Austin C. P., Figueroa D., MacNeil D., Cascieri M. A. Receptor for motilin identified in the human gastrointestinal system. Science. 1999 Jun 25;284(5423):2184–2188. doi: 10.1126/science.284.5423.2184. [DOI] [PubMed] [Google Scholar]
  4. Horowitz M., Wishart J. M., Jones K. L., Hebbard G. S. Gastric emptying in diabetes: an overview. Diabet Med. 1996 Sep;13(9 Suppl 5):S16–S22. [PubMed] [Google Scholar]
  5. Janssens J., Peeters T. L., Vantrappen G., Tack J., Urbain J. L., De Roo M., Muls E., Bouillon R. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. N Engl J Med. 1990 Apr 12;322(15):1028–1031. doi: 10.1056/NEJM199004123221502. [DOI] [PubMed] [Google Scholar]
  6. Maes B. D., Ghoos Y. F., Hiele M. I., Rutgeerts P. J. Gastric emptying rate of solids in patients with nonulcer dyspepsia. Dig Dis Sci. 1997 Jun;42(6):1158–1162. doi: 10.1023/a:1018881419010. [DOI] [PubMed] [Google Scholar]
  7. Nakajima T., Nawata H., Ito Y. Z-338, a newly synthetized carboxyamide derivative, stimulates gastric motility through enhancing the excitatory neurotransmission. J Smooth Muscle Res. 2000 Apr;36(2):69–81. doi: 10.1540/jsmr.36.69. [DOI] [PubMed] [Google Scholar]
  8. Peeters T., Matthijs G., Depoortere I., Cachet T., Hoogmartens J., Vantrappen G. Erythromycin is a motilin receptor agonist. Am J Physiol. 1989 Sep;257(3 Pt 1):G470–G474. doi: 10.1152/ajpgi.1989.257.3.G470. [DOI] [PubMed] [Google Scholar]
  9. Piessevaux H., Tack J., Wilmer A., Coulie B., Geubel A., Janssens J. Perception of changes in wall tension of the proximal stomach in humans. Gut. 2001 Aug;49(2):203–208. doi: 10.1136/gut.49.2.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Samsom M., Salet G. A., Roelofs J. M., Akkermans L. M., Vanberge-Henegouwen G. P., Smout A. J. Compliance of the proximal stomach and dyspeptic symptoms in patients with type I diabetes mellitus. Dig Dis Sci. 1995 Sep;40(9):2037–2042. doi: 10.1007/BF02208676. [DOI] [PubMed] [Google Scholar]
  11. Scott L. J., Perry C. M. Tegaserod. Drugs. 1999 Sep;58(3):491–498. doi: 10.2165/00003495-199958030-00013. [DOI] [PubMed] [Google Scholar]
  12. Stanghellini V., Tosetti C., Paternico A., Barbara G., Morselli-Labate A. M., Monetti N., Marengo M., Corinaldesi R. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology. 1996 Apr;110(4):1036–1042. doi: 10.1053/gast.1996.v110.pm8612991. [DOI] [PubMed] [Google Scholar]
  13. Tack J., Broeckaert D., Coulie B., Janssens J. The influence of cisapride on gastric tone and the perception of gastric distension. Aliment Pharmacol Ther. 1998 Aug;12(8):761–766. doi: 10.1046/j.1365-2036.1998.00366.x. [DOI] [PubMed] [Google Scholar]
  14. Tack J., Piessevaux H., Coulie B., Caenepeel P., Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology. 1998 Dec;115(6):1346–1352. doi: 10.1016/s0016-5085(98)70012-5. [DOI] [PubMed] [Google Scholar]
  15. Talley N. J. Review article: functional dyspepsia--should treatment be targeted on disturbed physiology? Aliment Pharmacol Ther. 1995 Apr;9(2):107–115. doi: 10.1111/j.1365-2036.1995.tb00359.x. [DOI] [PubMed] [Google Scholar]
  16. Talley N. J., Verlinden M., Geenen D. J., Hogan R. B., Riff D., McCallum R. W., Mack R. J. Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial. Gut. 2001 Sep;49(3):395–401. doi: 10.1136/gut.49.3.395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Talley N. J., Verlinden M., Snape W., Beker J. A., Ducrotte P., Dettmer A., Brinkhoff H., Eaker E., Ohning G., Miner P. B. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther. 2000 Dec;14(12):1653–1661. doi: 10.1046/j.1365-2036.2000.00868.x. [DOI] [PubMed] [Google Scholar]
  18. Undeland K. A., Hausken T., Aanderud S., Berstad A. Lower postprandial gastric volume response in diabetic patients with vagal neuropathy. Neurogastroenterol Motil. 1997 Mar;9(1):19–24. doi: 10.1046/j.1365-2982.1997.d01-3.x. [DOI] [PubMed] [Google Scholar]
  19. Verhagen M. A., Samsom M., Maes B., Geypens B. J., Ghoos Y. F., Smout A. J. Effects of a new motilide, ABT-229, on gastric emptying and postprandial antroduodenal motility in healthy volunteers. Aliment Pharmacol Ther. 1997 Dec;11(6):1077–1086. doi: 10.1046/j.1365-2036.1997.00260.x. [DOI] [PubMed] [Google Scholar]
  20. Zerbib F., Bruley Des Varannes S., Scarpignato C., Leray V., D'Amato M., Rozé C., Galmiche J. P. Endogenous cholecystokinin in postprandial lower esophageal sphincter function and fundic tone in humans. Am J Physiol. 1998 Dec;275(6 Pt 1):G1266–G1273. doi: 10.1152/ajpgi.1998.275.6.G1266. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES